FDA approves Hibsago (bepirovirsen) with NrtI therapy for adult chronic hepatitis B without cirrhosis; phase 3 trials show up to 20% functional cure at 72 weeks.
The recombinant zoster vaccine protects adults with HIV against cardiovascular complications such as incident heart failure ...
An infectious disease expert discusses using motivational interviewing and empathetic communication to address vaccine ...
META Older Latino adults show high motivation for RSV vaccination but face significant barriers to actual immunization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results